Nottingham, United Kingdom

Frank Kerrigan


Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 1997-2005

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Mind of Frank Kerrigan: Pioneering Antidepressant Agents

Introduction: Frank Kerrigan, a prolific inventor hailing from Nottingham, GB, is renowned for his groundbreaking work in the pharmaceutical realm. With a total of 7 patents to his name, Kerrigan's latest inventions focus on novel compounds as antidepressant agents, showcasing his commitment to improving mental health treatments.

Latest Patents: Among Kerrigan's recent patents are the development of dihydroimidazo[2,1-b]thiazole and dihydro-5H-thiazolo[3,2-a]pyrimidines. These compounds exhibit an affinity for 5-HT receptors, inhibit neuronal reuptake of neurotransmitters, and hold promise in treating a myriad of conditions such as depression, anxiety, schizophrenia, and even neurological disorders like epilepsy and stroke.

Career Highlights: Kerrigan's illustrious career includes stints at Knoll Aktiengesellschaft, where his expertise flourished, and his innovative spirit led to groundbreaking inventions in the pharmaceutical field. His dedication to advancing mental health treatments has earned him a prominent place in the industry.

Collaborations: Throughout his career, Kerrigan has collaborated with esteemed colleagues such as Sharon C. Cheetham and John Paul Watts. Together, they have pushed the boundaries of pharmaceutical research, paving the way for more effective and diverse treatment options.

Conclusion: Frank Kerrigan's inventive genius and unwavering commitment to improving healthcare have solidified his legacy as a trailblazer in the field of pharmaceuticals. His patents stand as a testament to his innovation and dedication to enhancing the quality of life for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…